Fighting flu: novel CD8 + T‐cell targets are required for future influenza vaccines
Clinical & Translational Immunology · 2024-01 · 13 (2)
DOI: 10.1002/cti2.1491 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical & Translational Immunology, online erschienen am 14.02.2024. Verfasst von Samuel Liwei Leong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science La Trobe University Bundoora VIC Australia. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: La Trobe University, National Health and Medical Research Council, Australian Institute of Nuclear Science and Engineering.
Abstract (Originalsprache)
Seasonal influenza viruses continue to cause severe medical and financial complications annually. Although there are many licenced influenza vaccines, there are billions of cases of influenza infection every year, resulting in the death of over half a million individuals. Furthermore, these figures can rise in the event of a pandemic, as seen throughout history, like the 1918 Spanish influenza pandemic (50 million deaths) and the 1968 Hong Kong influenza pandemic (~4 million deaths). In this review, we have summarised many of the currently licenced influenza vaccines available across the world and current vaccines in clinical trials. We then briefly discuss the important role of CD8 + T cells during influenza infection and why future influenza vaccines should consider targeting CD8 + T cells. Finally, we assess the current landscape of known immunogenic CD8 + T‐cell epitopes and highlight the knowledge gaps required to be filled for the design of rational future influenza vaccines that incorporate CD8 + T cells.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science La Trobe University Bundoora VIC Australia.
- Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute Monash University Clayton VIC Australia.
ORCID-Profile: Stephanie Gras
Förderung
- La Trobe University
- National Health and Medical Research Council
- Australian Institute of Nuclear Science and Engineering
- Australian Research Council
Zitieren
APA
Leong, S. L., Gras, S., & Grant, E. J. (2024). Fighting flu: novel CD8 + T‐cell targets are required for future influenza vaccines. Clinical & Translational Immunology, 13(2). https://doi.org/10.1002/cti2.1491
Vancouver
Leong SL, Gras S, Grant EJ. Fighting flu: novel CD8 + T‐cell targets are required for future influenza vaccines. Clinical & Translational Immunology. 2024;13(2). doi:10.1002/cti2.1491
BibTeX
@article{Leong2024,
author = {Leong, Samuel Liwei and Gras, Stephanie and Grant, Emma J},
title = {Fighting flu: novel CD8 + T‐cell targets are required for future influenza vaccines},
journal = {Clinical & Translational Immunology},
year = {2024},
volume = {13},
number = {2},
doi = {10.1002/cti2.1491}
}
EUVIMED